Found: 12
Select item for more details and to access through your institution.
Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma Patients.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3554, doi. 10.3390/jcm9113554
- By:
- Publication type:
- Article
Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5210, doi. 10.3390/cancers13205210
- By:
- Publication type:
- Article
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2885, doi. 10.3390/cancers12102885
- By:
- Publication type:
- Article
Hairy cell leukemia with isolated bone lesions.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Pomalidomide 3rd line versus 4th line for in Early Relapsed Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e258, doi. 10.1016/j.clml.2019.09.427
- By:
- Publication type:
- Article
Weekly 20/56mg/m2 Carfilzomib, Lenalidomide and Dexamethasone until progression in Early Relapsed Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e258, doi. 10.1016/j.clml.2019.09.426
- By:
- Publication type:
- Article
Le lénalidomide en association à la chimiothérapie d'induction classique pour le traitement des leucémies du sujet jeune : analyse de l'étude HOVON-SAKK-132 [1].
- Published in:
- Hematologie, 2021, v. 27, n. 2, p. 47, doi. 10.1684/hma.2021.1642
- By:
- Publication type:
- Article
Leucémie aiguë myéloïde avec mutation FLT3-TKD : bon ou mauvais pronostic ? Analyse du sous-groupe de l'essai RATIFY [1].
- Published in:
- Hematologie, 2020, v. 26, n. 6, p. 292, doi. 10.1684/hma.2020.1616
- By:
- Publication type:
- Article
Prise en charge de la splénomégalie chez les patients atteints de myélofibrose : quelles options en 2020 ?
- Published in:
- Hematologie, 2020, v. 26, n. 5, p. 225, doi. 10.1684/hma.2020.1598
- By:
- Publication type:
- Article
Avancées thérapeutiques dans les syndromes myélodysplasiques : quel traitement pour les bas risques en 2020 ? [1].
- Published in:
- Hematologie, 2020, v. 26, n. 4, p. 185, doi. 10.1684/hma.2020.1579
- By:
- Publication type:
- Article
Acalabrutinib : une véritable avancée pour la prise en charge de la leucémie lymphoïde chronique en rechute ou réfractaire?
- Published in:
- Hematologie, 2020, v. 26, n. 3, p. 146, doi. 10.1684/hma.2020.1557
- By:
- Publication type:
- Article
Actualisation à six ans de suivi des données de l'essai RESONATE : une confirmation de l'efficacité durable et de la bonne tolérance de l'ibrutinib en deuxième ligne pour les patients atteints de leucémie lymphoïde chronique
- Published in:
- Hematologie, 2020, v. 26, n. 1, p. 10, doi. 10.1684/hma.2020.1513
- By:
- Publication type:
- Article